Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment

American Journal of Veterinary Research

Volumn 64, Issue 8, 2003, Pages 1021-1026

  Martínez Subiela, Silvia ^a   Bernal, Luis J ^a   Cerón, José J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALLOPURINOL; AMYLOID A PROTEIN; C REACTIVE PROTEIN; CERULOPLASMIN; HAPTOGLOBIN; MEGLUMINE ANTIMONATE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOG; DRUG DOSE REGIMEN; DRUG RESPONSE; ELECTROPHORESIS; LEISHMANIA INFANTUM; LEISHMANIASIS; MONITORING; NONHUMAN; PROTEIN BLOOD LEVEL; RANDOMIZATION; REFERENCE VALUE; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE;

ACUTE-PHASE PROTEINS; ALLOPURINOL; ANIMALS; ANTIPROTOZOAL AGENTS; DOG DISEASES; DOGS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 17744405768     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.1021     Document Type: Article

References (29)

1. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 1982;389:39-48.
2. Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984;311:1413-1418.
3. Gruys E, Obwolo MJ, Toussaint MJ. Diagnostic significance of the mayor acute phase proteins in veterinary clinical chemistry: a review. Vet Bull 1994;64:1009-1018.
4. Martínez-Subiela S, Tecles F, Parra MD, et al. Acute phase proteins: general concepts and main clinical applications in veterinary medicine. An Vet (Murcia) 2001;17:99-116.
5. Moreno P, Lucena R, Ginel PJ. Evaluation of primary haemostasis in canine leishmaniasis. Vet Rec 1998;142:81-83.
6. Ashford W, Bettini S. Ecology and epidemiology: old world. In: Peters W, Killick-Kendrick R, eds. Leishmaniasis in biology and medicine. Vol I. Biology and epidemiology. London: Academic Press Inc, 1987;392-405.
7. Slapendel RJ, Ferrer L. Leishmaniasis. In: Green CE, ed. Infectious diseases of the dog and the cat. Philadelphia: WB Saunders Co, 1998;450-458.
8. Kager PA, Rees PH, Manguyu FM, et al. Clinical, haematological and parasitological response to treatment of visceral leishmaniosis in Kenya. A study of 64 patients. Trop Geogr Med 1984;36:21-35.
9. Wasunna KM, Raynes JG, Were JB, et al. Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis. Trans R Soc Trop Med Hyg 1995;89:678-681.
10. Singh UK, Patwari AK, Sinha RK, et al. Prognostic value of serum C-reactive protein in kala-azar. J Trop Pediatr 1999;45:226-228.
11. Martínez-Subiela S, Tecles F, Eckersall PD, et al. Serum concentrations of acute phase proteins in dogs with leishmaniasis. Vet Rec 2002;150:241-244.
12. Ginel PJ, Lucena R, López R, et al. Use of allopurinol for maintenance of remission in dogs with leishmaniasis. J Small Anim Pract 1998;39:271-274.
13. Denerolle P, Bourdoiseau G. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J Vet Intern Med 1999;13:413-415.
14. Martínez-Subiela S, Tecles F, Montes A, et al. Effects of haemolysis, lipaemia, bilirubinaemia and fibrinogen on protein electropherogram of canine samples analysed by capillary zone electrophoresis. Vet J 2003;164:261-268.
15. Eckersall PD, Duthie S, Safi S, et al. An automated biochemical assay for haptoglobin: prevention of the interference from albumin. Comp Haematol Int 1999;9:117-121.
16. Sunderman FW, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 1970;16:903-910.
17. Baneth G. Chemotherapy of canine leishmaniasis, in Proceedings. Int Can Leishmaniosis Forum 2001;37-43.
18. Ferrer L, Aisa MJ, Roura X, et al. Serological diagnosis and treatment of canine leishmaniasis. Vet Rec 1995;136:514-516.
19. Liste F, Gascon M. Allopurinol in the treatment of canine leishmaniasis. Vet Rec 1995;137:23-24.
20. Marr JJ. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J Lab Clin Med 1991;118:111-119.
21. Shapiro TA, Were JB, Danso K, et al. Pharmacokinetics and metabolism of allopurinol riboside. Clin Pharmacol Ther 1991; 49:506-514.
22. Lester SJ, Kenyon JE. Use of allopurinol to treat visceral leishmaniasis in a dog. J Am Vet Med Assoc 1996;209:615-617.
23. Harvey JW, West CL. Prednisone-induced increases in serum alpha-2-globulin and haptoglobin concentrations in dogs. Vet Pathol 1987;24:90-92.
24. Tosa N, Morimatsu M, Nakagawa M, et al. Purification and identification of a serum protein increased by anthelmintic drugs for Dirofilaria immitis in dogs. J Vet Med Sci 1993;55:27-31.
25. Ndung'u JM, Eckersall PD, Jennings FW. Elevation of the concentration of acute phase proteins in dogs infected with Trypanosoma brucei. Acta Trop 1991;49:77-85.
26. Martinez-Subiela S, Tecles f, Ceron JJ. Critical differences of acute phase protiens in canine serum samples. Available at:www.sciencedirect.com. Accessed Feb 1, 2003.
27. Groulade P. L'intérêt de l'electrophorèse des protéines sériques dans le bilan et le suivi au cours de la leishmaniose canine. Prat Méd Chir Amm Comp 1988;23:93-101.
28. Bourdoiseau G, Bonnefont C, Chabanne L, et al. Modifications sanguines (cellulaires et humorales) chez le chien leishmanien Suivi de chiens infectés traités et non traités. Revue Méd Vét 1997;148:219-228.
29. Valladares JE, Riera C, Gonzalez-Ensenyat P, et al. Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation. Vet Parasitol 2001;97:15-21.